BRIEF-Merck receives CHMP positive opinion for Keytruda in advanced non-small cell lung cancer
June 27, 2016 at 06:25 AM EDT
* Merck receives chmp positive opinion for keytruda (pembrolizumab) for the treatment of advanced non-small cell lung cancer (nsclc)
